Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells
US8669106B2 · kind B2 · utility
0Cited by
1References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2009 |
| Grant date | Mar 11, 2014 |
| Priority date | — |
| Expiry date | Apr 11, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides, among other things, methods and systems for expanding CD133+ cells. The invention further provides methods and systems for increasing the blood flow to an ischemic tissue in a subject in need thereof, such as to ischemic myocardium. The invention further provides methods and systems for directing differentiation of expanded CD133+ cells. The invention further provides methods and systems for treating a subject with differentiated cells in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.